AKI

TORONTO, July 17, 2026 Arch Biopartners Inc. has taken a significant step toward advancing its pre-Investigational New Drug (pre-IND)...

Cambridge, UK, July 17, 2026 Mission Therapeutics announced the divestment of its Phase 2-ready USP30 inhibitor MTX652 to Dimerix...

DENVER, July 14, 2026 SeaStar Medical announced its support for multiple educational initiatives aimed at improving the diagnosis and...

LA JOLLA, Calif., June 24, 2026 CalciMedica, Inc. announced that the U.S. Food and Drug Administration (FDA) has completed...

TORONTO, June 5, 2026 Edesa Biotech, Inc. announced new exploratory analyses demonstrating positive clinical signals for paridiprubart (EB05), its...

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

TORONTO, May 22, 2026 Arch Biopartners announced that Royal Columbian Hospital (RCH) in British Columbia has dosed its first...